(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

VINCERX PHARMA

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

VINCERX PHARMA

ST13

US500000090452781

Class

5, 42, 45

Filing

90452781

Registration

6726178

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

16

Latest update

05/24/2022

Trademark type

Word

Nice classes

5, 42, 45

Filing date

01/07/2021

Registration date

05/24/2022

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

05/24/2022

Last transaction

05/24/2022

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Intent to use

First use anywhere

06/10/2021

First use in commerce

06/10/2021

Drawing code

4

Owner type

03

Owner location

Palo Alto, CA

Examiner

LE, MARGARET

Law office

M90

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

Vincerx Pharma, Inc.
Vincerx Pharma, Inc.

Representatives

Patricia L. Cotton PILLSBURY WINTHROP SHAW PITTMAN LLP

Technical classification

Nice Classes

Class 5Class 42Class 45

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Pharmaceutical preparations for the treatment of cancer

Class 42

Scientific research and analysis in the fields of pharmaceuticals and biologics for the treatment of cancer; providing scientific research information relating to pharmaceutical preparations and biologic preparations for the treatment of cancer

Class 45

Licensing of scientific technology to third parties in the fields of pharmaceuticals and biologics for the treatment of cancer

Publications

History of USPTO decisions and trademark events.

16 publications found

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

05/24/2022

R.PR

REGISTERED-PRINCIPAL REGISTER

05/24/2022

SUNA

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

04/07/2022

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

04/06/2022

SUPC

STATEMENT OF USE PROCESSING COMPLETE

04/05/2022

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

03/29/2022

IUAF

USE AMENDMENT FILED

03/03/2022

EISU

TEAS STATEMENT OF USE RECEIVED

03/03/2022

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

10/19/2021

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

08/24/2021

PUBO

PUBLISHED FOR OPPOSITION

08/24/2021

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

08/04/2021

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

07/22/2021

DOCK

ASSIGNED TO EXAMINER

07/16/2021

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

04/06/2021

NWAP

NEW APPLICATION ENTERED

01/11/2021

Continuous trademark protection

Get notified about every new filing that threatens VINCERX PHARMA or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.